XML 43 R36.htm IDEA: XBRL DOCUMENT v3.26.1
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Award Activity

The following is a summary of the Company’s stock option award activity under the 2024 Plan and 2026 Plan during the six months ended June 30, 2026:

 

 

 

Number
of Stock
Options

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Term (in years)

 

 

Aggregate
Intrinsic
Value
(in thousands)

 

Outstanding at December 31, 2025

 

 

8,569,619

 

 

$

4.60

 

 

 

8.67

 

 

$

28,669

 

Granted

 

 

4,211,692

 

 

 

16.05

 

 

 

 

 

 

 

Exercised

 

 

(216,075

)

 

 

3.74

 

 

 

 

 

 

1,421

 

Forfeited

 

 

(331,437

)

 

 

5.10

 

 

 

 

 

 

 

Expired

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at June 30, 2026

 

 

12,233,799

 

 

$

8.55

 

 

 

8.60

 

 

$

161,146

 

Vested and expected to vest at June 30, 2026

 

 

12,233,799

 

 

$

8.55

 

 

 

8.60

 

 

$

161,146

 

Exercisable at June 30, 2026

 

 

8,576,419

 

 

$

8.44

 

 

 

8.47

 

 

$

113,853

 

Schedule of Ranges of Assumptions Used in Black-Scholes Option-Pricing Model The following table presents the ranges of assumptions used by the Company in the Black-Scholes option-pricing model during the six months ended June 30, 2026 and 2025:

 

 

June 30,

 

2026

 

2025

Expected term (in years)

5.00 - 6.11 years

 

5.19 - 6.08 years

Risk-free interest rate

3.59% - 4.08%

 

3.93% - 4.39%

Volatility

90.36% - 94.23%

 

89.40% - 91.63%

Dividend yield

0.00%

 

0.00%

Summary of Restricted Stock Award Activity

The following is a summary of the Company’s restricted stock award activity during the six months ended June 30, 2026:

 

 

 

Number
of Units

 

 

Weighted-
Average
Fair Value

 

Unvested at December 31, 2025

 

 

154,778

 

 

$

3.05

 

Vested

 

 

(154,778

)

 

 

3.05

 

Unvested at June 30, 2026

 

 

 

 

$

 

Schedule of Stock-Based Compensation Expense

The following table represents stock-based compensation expense recorded in the Company’s condensed consolidated statements of operations and comprehensive loss (in thousands):

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Research and development

$

898

 

 

$

589

 

 

$

1,789

 

 

$

1,086

 

General and administrative

 

35,965

 

 

 

1,167

 

 

 

37,643

 

 

 

2,289

 

Stock-based compensation expense

$

36,863

 

 

$

1,756

 

 

$

39,432

 

 

$

3,375